YM 207

Drug Profile

YM 207

Alternative Names: Humanised anti-C4G1 monoclonal antibody; Y1-antibody

Latest Information Update: 22 Sep 1998

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Yamanouchi
  • Class Antiplatelets; Monoclonal antibodies; Vascular disorder therapies
  • Mechanism of Action GPIIb-IIIa antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Arterial thrombosis; Myocardial infarction

Most Recent Events

  • 22 Sep 1998 No-Development-Reported for Arterial thrombosis in Japan (Unknown route)
  • 22 Sep 1998 No-Development-Reported for Myocardial infarction in Japan (Unknown route)
  • 26 Sep 1995 An animal study was added to the Thromboses pharmacodynamics section
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top